5395242026-07-30Disclosure45395242026-07-30Disclosure35395242026-07-30Disclosure25395242026-07-30Disclosure15395242026-07-30Disclosure135395242026-07-30Disclosure125395242026-07-30Disclosure115395242026-07-30Disclosure95395242026-07-30Disclosure105395242026-07-30Disclosure85395242026-07-30Disclosure75395242026-07-30Disclosure65395242026-07-30Disclosure55395242026-07-30Disclosure145395242026-07-30xbrli:sharesxbrli:pureiso4217:INR

Prohibition of Insider Trading


DR. LAL PATHLABS LIMITED

General information about company

Scrip Code539524
NSE SymbolLALPATHLAB
MSEI SymbolNOTLISTED
Name of the SignatoryVINAY GUJRAL
Designation of SignatoryCompany Secretary and Compliance Officer
PlaceGURUGRAM
Date of Filing30-07-2026
ISIN CodeINE600L01024
Disclosure under RegulationRegulation 7 (2)
Revised FilingNo

PIT Disclosure

Sr. No.Type of instrumentDescription of type of instrument (applicable in case of other is selected)Category of personName of the personCIN / DINSecurities held prior to acquisition / disposalSecurities acquired / disposedSecurities held post acquisition / disposalDate of allotment advice / acquisition of shares / sale of shares specifyMode of acquisition / disposalDate of intimation to companyType of contractContract specificationBuySellExchange on which the trade was executedNotes
No. of security% of shareholdingNo. of securityValue of security (in Rs.)Transaction typeNo. of security% of shareholdingFrom dateTo dateNotional valueNo. of units (contracts × lot size)Notional valueNo. of units (contracts × lot size)
1EquityOtherDr. Lal PathLabs Employee Welfare Trust6381000.38%298006,928,207.00Sell6083000.36%27-07-202629-07-2026ESOP29-07-2026NATextual Information(1)
2EquityDesignated PersonPrashant Kishore48000.00%6981,276,400.00Sell41020.00%28-07-202629-07-2026Market Sale29-07-2026NSE
3EquityDesignated PersonAbhishek Aggarwal15000.00%15002,820,250.00Sell00.00%29-07-202629-07-2026Market Sale30-07-2026BSE
4EquityDesignated PersonAbhishek Aggarwal00.00%1250818,103.00Buy12500.00%30-07-202630-07-2026ESOP30-07-2026NATextual Information(2)
5EquityKMPShankha Banerjee575200.03%250012,500.00Buy600200.04%27-07-202627-07-2026ESOP29-07-2026NATextual Information(3)
6EquityDesignated PersonJai Prakash Meena26000.00%28002,702,084.00Buy54000.00%29-07-202629-07-2026ESOP30-07-2026NATextual Information(4)
7EquityDesignated PersonMunender Soperna355200.02%450022,500.00Buy400200.02%27-07-202627-07-2026ESOP29-07-2026NATextual Information(5)
8EquityDesignated PersonMunender Soperna400200.02%700012,952,890.00Sell330200.02%27-07-202629-07-2026Market Sale29-07-2026BSE
9EquityDesignated PersonMunender Soperna330200.02%11002,039,114.00Sell319200.02%29-07-202629-07-2026Market Sale29-07-2026NSE
10EquityDesignated PersonManoj Kumar Garg559000.03%500937,500.00Sell554000.03%27-07-202627-07-2026Market Sale30-07-2026NSE
11EquityDesignated PersonManoj Kumar Garg554000.03%500937,500.00Sell549000.03%29-07-202629-07-2026Market Sale30-07-2026BSE
12EquityOtherDr. Lal PathLabs Employee Welfare Trust6083000.36%20501,146,844.00Sell6062500.36%30-07-202630-07-2026ESOP30-07-2026NATextual Information(6)
13EquityKMPVed Prakash Goel415540.02%1365068,250.00Buy552040.03%27-07-202627-07-2026ESOP29-07-2026NA
14EquityKMPVed Prakash Goel552040.03%30005,666,000.00Sell522040.03%27-07-202629-07-2026Market Sale29-07-2026NSE

Text Block

Textual Information(1)It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 965.03 /-, 5/-, 1087.47/- per share (as the case may be) under Company’s ESOP plan(s).
Textual Information(2)It may be kindly noted that shares were acquired at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/-, 1087.47/- per share (as the case maybe) under Company’s ESOP plan
Textual Information(3)It may be kindly noted that shares were acquired at an exercise price of INR 5/- per share under Company’s ESOP plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015. However, the above is being informed due to the fact that the Market Value of these shares exceeds the limit prescribed under Regulation 7(2)(a).
Textual Information(4)It may be kindly noted that shares were acquired at an Exercise price of INR 965.03 /- per share under Company’s ESOP plan and their value does not exceed the limit prescribed under Regulation 7(2)(a) of SEBI (Prohibition of Insider Trading) regulations, 2015.
Textual Information(5)It may be kindly noted that shares were acquired at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/- per share under Company’s ESOP plan.
Textual Information(6)It may be kindly noted that shares were transferred at Effective Exercise price (Post Bonus Issue- 2025) of INR 5/-, 1087.47/- per share (as the case may be) under Company’s ESOP plan(s).